Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Certificate of Incorporation of Citius Oncology, Inc
- 3.2 Bylaws of Citius Oncology, Inc
- 10.1 Amended and Restated Registration Rights Agreement, Dated As of August 12, 2024 by and Between Citius Oncology, Inc. and the Signatories Thereto
- 10.2 Amended and Restated Shared Services Agreement, Dated As of August 12, 2024, by and Among Citius Oncology, Inc. and Citius Pharmaceuticals, Inc
- 10.8 Side Letter Agreement, Dated August 12, 2024, by and by and Among Citius Pharmaceuticals, Inc., Citius Oncology, Inc., Tenx Keane Acquisition and Tenx Merger Sub, Inc
- 10.9 Promissory Note, Dated August 16, 2024, by and Between Citius Oncology, Inc. and Citius Pharmaceuticals, Inc.
- 16.1 Letter from Marcum LLP to the Securities and Exchange Commission, Dated August 16, 2024
- 21.1 Subsidiaries of Citius Oncology, Inc
- Download Excel data file
- View Excel data file
CTOR similar filings
- 13 Sep 24 Entry into a Material Definitive Agreement
- 5 Sep 24 Other Events
- 26 Aug 24 Completion of Acquisition or Disposition of Assets
- 16 Aug 24 Entry into a Material Definitive Agreement
- 2 Aug 24 Departure of Directors or Certain Officers
- 19 Jul 24 Entry into a Material Definitive Agreement
- 18 Jun 24 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 21.1
List of Subsidiaries of Citius Oncology, Inc.
| Name of Subsidiary | Jurisdiction of Incorporation | |
| Citius Oncology Sub, Inc. | Delaware |